< Back to latest news & events

Event

IP Seminar – Practical Tips to Maximise Success in EPO Oppositions and Appeals – Basel

January 2019

Event date: 16th January 2019

HGF are hosting a seminar on practical tips to maximise success in EPO oppositions and appeals at Der Teufelhof Basel on Wednesday 16th January at 6:00pm.

The opposition procedure of the European Patent Office (EPO) provides a very cost-efficient way to challenge patents granted by the EPO.  However, securing a successful outcome requires careful planning and creative thinking to effectively deal with issues that can arise in the heat of a hearing.

Partner, Gareth Probert and Patent Director, Joanna Deas will provide an overview of the opposition and appeal process and what you can expect if somebody opposes one of your patents or if you want to attack a patent of one of your competitors.  They will focus on the practical side of handling an opposition and share with you their tips and advice based on their experiences of handling more than 200 opposition and appeals.

They will also explore how some of the recent changes to the opposition procedure introduced by the EPO could influence your opposition strategy. Looking to the future, they will also discuss what you need to do now ready for when your cases are handled by the modernised Boards of Appeal as radical changes are introduced in 2019.

We hope the seminar will be of interest to innovator companies with patents as well as patent professionals.

The seminar is free to attend. To register please contact Liz Davies or call +44 (0)113 233 0189.

Gareth Probert, Partner and Head of HGF Nottingham

Gareth is an Opposition and Appeal specialist and is very experienced at representing clients in proceedings at all levels of the European Patent Office. He has achieved many successes in high value and business-critical oppositions, often working in conjunction with parallel national litigation. Gareth and his team organise mock hearings in preparation for significant cases. He focusses on medical technology, pharmaceutical and life sciences cases, and also has considerable experience in the FMCG and food sectors.

Joanna Deas, Patent Director

Joanna is a European Patent Attorney and is based in HGF’s office in Nottingham.

Joanna specialises in representing clients at EPO Opposition and Appeal hearings, and regularly attends hearings in Munich and The Hague. Joanna has particular expertise in medical technologies such as medical devices and processes, and her practice also includes working in other areas such as chemistry, formulations, polymers and pharmaceuticals. She been responsible for a number of high profile cases for a well-known FMCG company. She has also been involved in important mock hearings for several clients.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article